Reviews in Endocrine & Metabolic Disorders

Papers
(The TQCC of Reviews in Endocrine & Metabolic Disorders is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Association between continuous glucose monitoring metrics and cardiovascular autonomic neuropathy in diabetic patients: a systematic review168
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality164
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health118
Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus112
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus93
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review91
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?79
Traumatic brain injury and prolactin79
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review69
Endocrine responses of the stress system to different types of exercise60
The genetics of Graves’ disease60
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review58
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb52
Diagnostic and prognostic utility of phase angle in patients with cancer49
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease46
Posttranslational modifications in diabetes: Mechanisms and functions45
Prolactin deficiency in the context of other pituitary hormone abnormalities45
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic43
Preface43
Androgens, aging, and prostate health42
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease42
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond42
Hypothalamic GHRH41
Mention to Prof. Andrew V. Schally41
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries41
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence40
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review38
Deep neural network for food image classification and nutrient identification: A systematic review38
Neurovascular plasticity as a modulator of hypothalamic function37
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy36
Appetitive interoception, the hippocampus and western-style diet35
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis35
No longer to be ignored: Hypophosphatemia following intravenous iron administration35
Towards precision medicine in non-alcoholic fatty liver disease33
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities33
Ciliopathies are responsible for short stature and insulin resistance: A systematic review of this clinical association regarding SOFT syndrome33
The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations33
Correction: Hypothalamic GHRH33
Diagnostic accuracy of bilateral inferior petrosal sinus sampling using desmopressin or corticotropic- releasing hormone in ACTH-dependent Cushing’s syndrome: A systematic review and meta-analysis32
Real-world evidence of effectiveness and safety of pasireotide in the treatment of acromegaly: a systematic review and meta-analysis32
Novel treatments for congenital adrenal hyperplasia31
Food cue reactivity: Neurobiological and behavioral underpinnings30
Computational approaches to predicting treatment response to obesity using neuroimaging29
Uterine fibroids in women diagnosed with acromegaly: a systematic review29
Rathke’s cleft cyst: From history to molecular genetics28
Malnutrition management of hospitalized patients with diabetes/hyperglycemia and COVID-19 infection28
Regulation of adipogenesis by exosomal milk miRNA27
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review27
Correction to: Chemotherapy in NEN: still has a role?27
Hidden chronic metabolic acidosis of diabetes type 2 (CMAD): Clues, causes and consequences26
Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects26
Prolactin: structure, receptors, and functions26
GHRH in diabetes and metabolism25
ATP-consuming futile cycles as energy dissipating mechanisms to counteract obesity25
Molecular testing for thyroid nodules: Where are we now?25
Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients25
The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies25
The emerging role of transcription factor FOXP3 in thyroid cancer24
Hypoprolactinemia, a neglected endocrine disorder24
Gut-brain mechanisms underlying changes in disordered eating behaviour after bariatric surgery: a review23
Endogenous Cushing’s syndrome during pregnancy23
Phase angle in localized bioimpedance measurements to assess and monitor muscle injury22
Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications22
Phase angle as an index of physiological status: validating bioelectrical assessments of hydration and cell mass in health and disease22
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity22
Phase angle in applications of bioimpedance in health and disease22
Phase angle and COVID-19: A systematic review with meta-analysis21
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions21
Contribution of the microbiome for better phenotyping of people living with obesity21
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities21
BBSome: An essential component of hypothalamic regulation of energy homeostasis21
Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE Group20
Reference intervals for serum prolactin concentrations: analytical and clinical considerations20
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management20
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes19
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases19
Surgical outcomes of partial adrenalectomy for pheochromocytoma: A systematic review and meta-analysis18
Efficacy of radiofrequency and laser thermal ablation in solving thyroid nodule-related symptoms and cosmetic concerns. A systematic review and meta-analysis18
Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing18
0.058836221694946